SAN FRANCISCO, July 10, 2025 (GLOBE NEWSWIRE) -- Biotechnology firm Iovance Biotherapeutics Inc. (NASDAQ: IOVA) announced a significant leadership transition, confirming the resignation of Chief Financial Officer Jean-Marc Bellemin, effective July 10, 2025. Mr. Bellemin, who assumed the CFO role in November 2020, is reportedly departing to pursue other endeavors, according to a regulatory filing. Bellemin’s exit comes at a tumultuous time, as the company is grappling with a recent commercial setback for its ...

PHILADELPHIA, July 10, 2025 /PRNewswire/ -- Berger Montague PC advises investors that a securities class action lawsuit has been filed against Elevance Health, Inc. ("Elevance" or the "Company") (NYSE: ELV) on behalf of purchasers of Elevance securities between April 18, 2024 through October 16, 2024, inclusive (the "Class Period").Investor Deadline: Investors who purchased or acquired Elevance securities during the Class Period may, no later than JULY 11, 2025, seek to be appointed as a lead plaintiff repr ...

Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, July 09, 2025 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Petco Health and Wellness Company, Inc. ("Petco" or the "Company") (NASDAQ: WOOF) investors of a class action representing investors that bought securities between January 14, 2021 and June 5, 2025, inclusive (the "Class Period"). Petco investors have until August 29, 2025 to file a lead plaintiff motion. Investors are encouraged to contact att ...

Core Viewpoint - A class action lawsuit has been filed against iRobot Corporation, alleging that the company misrepresented the effectiveness of its restructuring plan following a failed merger with Amazon, leading to significant investor losses [3][4]. Group 1: Lawsuit Details - The class action represents investors who purchased iRobot securities between January 29, 2024, and March 11, 2025, with a deadline of September 5, 2025, to file a lead plaintiff motion [1]. - The lawsuit claims that iRobot overstated the stability provided by its restructuring plan, raising doubts about its long-term viability as an independent company [3]. Group 2: Financial Performance - iRobot reported a loss of $2.06 per share for Q4 and the full year 2024, with revenue of $172 million, marking a 44% decline from the previous year [4]. - The company's statement indicated "substantial doubt" about its ability to continue as a going concern for at least the next 12 months, which led to a stock price drop of over 51% following the announcement [4].

SAN FRANCISCO, July 09, 2025 (GLOBE NEWSWIRE) -- On June 25, 2025, two securities class action lawsuits were filed against Hims & Hers Health, Inc. (NYSE: HIMS) and certain of the company’s executives. Sookdeo v. Hims & Hers Health, Inc., et al., No. 3:25-cv-05315 (N.D. Cal.) and Yaghsizian v. Hims & Hers Health, Inc. et al., No. 3:25-cv-05321 (N.D. Cal.). Together, the cases seek to represent investors who purchased or otherwise acquired Hims & Hers securities between April 29, 2025 and June 23, 2025. The ...

NEW YORK, July 09, 2025 (GLOBE NEWSWIRE) -- Class Action Attorney Juan Monteverde with Monteverde & Associates PC (the “M&A Class Action Firm”), has recovered millions of dollars for shareholders and is recognized as a Top 50 Firm in the 2024 ISS Securities Class Action Services Report. The firm is headquartered at the Empire State Building in New York City and is investigating Core Scientific, Inc. (NASDAQ: CORZ) related to its sale to CoreWeave, Inc. Upon completion of the proposed transaction, each outst ...

Core Insights - Class Action Attorney Juan Monteverde's firm, Monteverde & Associates PC, is investigating PB Bankshares Inc. in relation to its proposed sale to Norwood Financial Corp. [1] - The transaction offers PB Bankshares' shareholders the choice of receiving either 0.7850 shares of Norwood common stock or $19.75 in cash for each common share they own, with a proration clause ensuring that 80% of the total consideration is paid in Norwood stock [1] Company Overview - Monteverde & Associates PC is recognized as a Top 50 Firm in the 2024 ISS Securities Class Action Services Report and has a successful track record in recovering millions for shareholders [1] - The firm operates from the Empire State Building in New York City and specializes in class action securities litigation [2] Transaction Details - The proposed sale of PB Bankshares to Norwood Financial Corp. includes an option for shareholders to elect their preferred form of compensation, either stock or cash [1] - The proration mechanism is designed to ensure that a significant majority (80%) of the transaction consideration is distributed in the form of Norwood common stock [1]

RADNOR, Pa., July 8, 2025 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed against Sarepta Therapeutics, Inc. ("Sarepta") (NASDAQ: SRPT) on behalf of those who purchased or otherwise acquired Sarepta securities between June 22, 2023, and June 24, 2025, inclusive (the "Class Period"). The lead plaintiff deadline is August 25, 2025.CONTACT KESSLER TOPAZ MELTZER & CHECK, LLP:If you suffered Sarepta losses, ...

ATLANTA, July 08, 2025 (GLOBE NEWSWIRE) -- A shareholder class action lawsuit has been filed against Red Cat Holdings, Inc. (“Red Cat” or the “Company”) (NASDAQ: RCAT). The lawsuit alleges that Defendants made materially false and/or misleading statements and/or failed to disclose material adverse information, including allegations that: (i) the Salt Lake City Facility’s production capacity, and Defendants’ progress in developing the same, was overstated; (ii) the overall value of the SRR Contract was overs ...

NEW YORK, July 08, 2025 (GLOBE NEWSWIRE) -- WHY: New York, N.Y., July 8, 2025. Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Compass Diversified Holdings (NYSE: CODI) between March 1, 2023, and May 7, 2025, both dates inclusive (the “Class Period”), of the important July 8, 2025 lead plaintiff deadline in the securities class action first filed by the Firm. SO WHAT: If you purchased Compass securities you may be entitled to compensation without payment of any out of ...